XT
NVS icon

XTX Topco’s Novartis NVS Stock Holding History

XTX Topco’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76M Sell
11,248
-49,318
-81% -$7.39M 0.02% 1240
2026
Q1 		$9.25M Buy
60,566
+44,077
+267% +$6.76M 0.16% 78
2025
Q4 		$2.27M Buy
16,489
+10,862
+193% +$1.42M 0.06% 480
2025
Q3 		$722K Sell
5,627
-3,586
-39% -$438K 0.04% 799
2025
Q2 		$1.11M Buy
9,213
+6,932
+304% +$781K 0.05% 596
2025
Q1 		$254K Sell
2,281
-8,098
-78% -$862K 0.01% 1531
2024
Q4 		$1.01M Sell
10,379
-20,140
-66% -$2.15M 0.08% 296
2024
Q3 		$3.51M Buy
+30,519
New +$3.46M 0.25% 32
2024
Q1 		– Sell
-4,519
Closed -$456K – 2163
2023
Q4 		$456K Buy
+4,519
New +$436K 0.1% 316
2022
Q4 		– Sell
-3,899
Closed -$296K – 1387
2022
Q3 		$296K Buy
+3,899
New +$323K 0.07% 513
2022
Q1 		– Sell
-5,972
Closed -$522K – 879
2021
Q4 		$522K Buy
+5,972
New +$496K 0.3% 66

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco's NVS Position: Q2 2026 in Review

XTX Topco reduced its Novartis (NVS) stake by 81% in Q2 2026, selling an estimated $7.39M and leaving 11,248 shares worth $1.76M. The position accounts for 0.02% of the portfolio, ranked #1240.

XTX Topco first reported a position in NVS in Q4 2021 and has held it in 11 quarters since. The position peaked at $9.25M in Q1 2026. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • XTX Topco held 11,248 shares of Novartis worth $1.76M as of Q2 2026.
  • XTX Topco sold 49,318 Novartis shares in Q2 2026, an estimated $7.39M.
  • Novartis made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1240 holding.
  • XTX Topco first reported a position in Novartis in Q4 2021 and has held it in 11 quarters since.
  • XTX Topco's Novartis position peaked at $9.25M in Q1 2026.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.